Rates of severe infection after transrectal ultrasound-guided (TRUS) prostate biopsy that require hospitalization are on the rise, a population-based Swedish study shows. "Over 100,000 biopsies are ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...

Artera has secured CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI prostate ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

Misdiagnoses in prostate biopsy patients lead to $880M in healthcare costs On average, roughly one in every 200 patients undergoing a prostate biopsy are misdiagnosed due to their biopsy specimens ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

For men aged 50-69 years who underwent a one-time prostate-specific antigen (PSA) screening for prostate cancer, a lower prostate cancer-specific mortality was observed after 15 years of follow-up, ...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...

Forbes contributors publish independent expert analyses and insights. Bruce Y. Lee, M.D., MBA, covers health, medicine, wellness and science International Tennis Hall-of-Famer Björn Borg serves up ...